- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01572311
Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2) (HM2)
October 24, 2014 updated by: Robert Petrella, MD, Parkwood Hospital, London, Ontario
Study of Community Based Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults Without Dementia
The investigators proposed research will establish whether combining aerobic exercise with cognitive challenges is feasible and effective in community dwelling older adults with early signs of cognitive impairment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To determine the effects of dual-task aerobic exercise training on community dwelling older adults with early signs of cognitive impairment.
We will compare an exercise intervention (E-I) versus an exercise control (E-C) group.
Each week, both groups will accumulate a minimum of 120 minutes of exercise (target 150 minutes) from community-based group classes (50 minutes of aerobic exercise) and also complete 45 minutes of beginner-level Square Stepping Exercise (SSE).
The E-I group will also answer cognitively challenging questions while doing SSE (dual-task training).
This study will determine whether a combined multiple modality (primary component being aerobic exercise) and dual-task exercise program is both feasible and effective for improving cognitive and mobility status, as well as vascular compliance, in older adults who may be at risk for cognitive and mobility decline.
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6C 5J1
- Aging, Rehabilitation and Geriatric Care Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male/Female 55-90 years old.
- Montreal Cognitive Assessment score ≤27
- Preserved Instrumental Activities of Daily Living (based on Lawton-Brody Instrumental Activities of Daily Living Sale)
Exclusion Criteria:
- Dementia (i.e., Mini-Mental Examination score <24 or self-reported physician diagnosis)
- Major Depression (>=16 on the Center for Epidemiologic Studies - Depression Scale combined with clinical judgment by primary study physician)
- Other neurological or psychiatric disorders
- Recent history of severe cardiovascular conditions
- Significant orthopedic conditions
- Have blood pressure >180/100 mmHg or <100/60 mmHg
- Unable to comprehend questionnaire material/study procedures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise Intervention Group
For 26 weeks, attend Canadian Centre for Activity and Aging combined classes (75-minute or 60-minute classes, 2 to 3 days/week) and also complete 45 minutes of dual-task gait training (15 minutes for 3 days/week or 22.5 minutes for 2 days/week)
|
Goal of 150 minutes of structured exercise/week; minimum of 120 minutes from CCAA classes/week.
The 75-minute class includes: 5-minute warm-up; 25 minutes of AE (70-85% maximum heart rate); 5-minute cool-down; 20 minutes of strength training; 5 minutes of core strengthening; 5 minutes of balance training; and 10 minutes of stretching.
The 60-minute program is identical except: 15 minutes total for all strength training (including core) and 5 minutes of stretching.
Following CCAA classes, participants continue with dual-task gait training where they are required to walk on a special mat with a designated walking pattern (beginner level Square Stepping Exercise) while answering cognitively challenging questions.
Other Names:
|
Active Comparator: Exercise Control group
For 26 weeks, attend Canadian Centre for Activity and Aging combined classes (75-minute or 60-minute classes, 2 to 3 days/week) and also complete 45 minutes of gait training (15 minutes for 3 days/week or 22.5 minutes for 2 days/week).
Note: no dual-task challenges during gait training
|
Goal of 150 minutes of structured exercise/week; minimum of 120 minutes from CCAA classes/week.
The 75-minute class includes: 5-minute warm-up; 25 minutes of AE (70-85% maximum heart rate); 5-minute cool-down; 20 minutes of strength training; 5 minutes of core strengthening; 5 minutes of balance training; and 10 minutes of stretching.
The 60-minute program is identical except: 15 minutes total for all strength training (including core) and 5 minutes of stretching.
Following CCAA classes, participants continue with gait training where they are required to walk on a special mat with a designated walking pattern (beginner level Square Stepping Exercise).
This will not include any dual-task challenges.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global cognitive functioning
Time Frame: 26 weeks
|
Four standardized domain-specific composite scores were averaged to create this standardized global cognitive functioning score (incorporates executive function, processing speed, verbal learning and memory, and verbal fluency.
|
26 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global cognitive functioning
Time Frame: 12 & 52 weeks
|
Four standardized domain-specific composite scores were averaged to create this standardized global cognitive functioning score (incorporates executive function, processing speed, verbal learning and memory, and verbal fluency.
|
12 & 52 weeks
|
Executive Function/Mental Flexibility
Time Frame: 12, 26, and 52 weeks
|
Standardized scores from seconds to complete Trail Making Test Part A and Trail Making Test Part B averaged to create this standardized composite score
|
12, 26, and 52 weeks
|
Processing Speed
Time Frame: 12, 26 and 52 weeks
|
Standardized score from the Digit-Symbol Substitution Test (total correct responses)
|
12, 26 and 52 weeks
|
Verbal Learning and Memory
Time Frame: 12, 26 and 52 weeks
|
Standardized scores from Auditory Verbal Learning Test (number of words learned and number of words recalled) were averaged to create this standardized composite score
|
12, 26 and 52 weeks
|
Verbal Fluency
Time Frame: 12, 26 and 52 weeks
|
Standardized scores from semantic (number of animals) and phonemic (number of words starting with C) were averaged to create this standardized composite score
|
12, 26 and 52 weeks
|
Gait variability (step length) under dual-task conditions
Time Frame: 12, 26 and 52 weeks
|
Gait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as coefficient of variation of step length (SD/mean x 100).
Measured with GAITRite system.
|
12, 26 and 52 weeks
|
Gait variability (step length) under single-task conditions
Time Frame: 12, 26 and 52 weeks
|
Gait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as coefficient of variation of step length (SD/mean x 100).
Measured with GAITRite system.
|
12, 26 and 52 weeks
|
Gait speed under dual-task conditions
Time Frame: 12, 26 and 52 weeks
|
Average walking speed measured with GAITRite system
|
12, 26 and 52 weeks
|
Gait speed under single-task conditions
Time Frame: 12, 26 and 52 weeks
|
Average walking speed measured with GAITRite system
|
12, 26 and 52 weeks
|
Double support (seconds and % gait cycle time) under dual-task conditions
Time Frame: 12, 26 and 52 weeks
|
Initial double support occurs from heel contact of one footfall to toe-off of the opposite footfall.
Terminal double support occurs from opposite footfall heel strike to support footfall toe-off.Total double support is the sum of the initial double support added to the terminal double support.
It is measured in seconds (sec) and also expressed as a percent of the Gait Cycle time for the same foot.
Measured with GAITRite system
|
12, 26 and 52 weeks
|
Double support (seconds and % gait cycle time) under single-task conditions
Time Frame: 12, 26 and 52 weeks
|
Initial double support occurs from heel contact of one footfall to toe-off of the opposite footfall.
Terminal double support occurs from opposite footfall heel strike to support footfall toe-off.Total double support is the sum of the initial double support added to the terminal double support.
It is measured in seconds (sec) and also expressed as a percent of the Gait Cycle time for the same foot.
Measured with GAITRite system
|
12, 26 and 52 weeks
|
Step length under dual-task conditions
Time Frame: 12, 26 and 52 weeks
|
Mean step length measured with GAITRite system
|
12, 26 and 52 weeks
|
Step length under single-task conditions
Time Frame: 12, 26 and 52 weeks
|
Mean step length measured with GAITRite system
|
12, 26 and 52 weeks
|
Carotid artery compliance
Time Frame: 12, 26 and 52 weeks
|
Measured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck)
|
12, 26 and 52 weeks
|
Carotid artery Intima-media thickness (IMT)
Time Frame: 12, 26 and 52 weeks
|
Measured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck)
|
12, 26 and 52 weeks
|
Ambulatory systolic blood pressure
Time Frame: 12, 26 and 52 weeks
|
Average systolic blood pressure over a 24-hour time frame
|
12, 26 and 52 weeks
|
Clinic systolic blood pressure
Time Frame: 12, 26 and 52 weeks
|
Average systolic blood pressure from final 2 (out of 3) readings
|
12, 26 and 52 weeks
|
Ambulatory diastolic blood pressure
Time Frame: 12, 26 and 52 weeks
|
Average diastolic blood pressure over a 24-hour time frame
|
12, 26 and 52 weeks
|
Clinic diastolic blood pressure
Time Frame: 12, 26 and 52 weeks
|
Average diastolic blood pressure from final 2 (out of 3) readings
|
12, 26 and 52 weeks
|
Total balance score
Time Frame: 12, 26, and 52 weeks
|
Total balance score calculated from the Fullerton Advanced Balance Scale
|
12, 26, and 52 weeks
|
Total Falls Self-Efficacy score
Time Frame: 12, 26, and 52 weeks
|
Total falls self-efficiacy score calculated from the Falls Self-Efficacy International (FES-I) scale
|
12, 26, and 52 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Robert J Petrella, MD., PhD., Lawson Health Research Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
May 1, 2014
Study Registration Dates
First Submitted
April 3, 2012
First Submitted That Met QC Criteria
April 5, 2012
First Posted (Estimate)
April 6, 2012
Study Record Updates
Last Update Posted (Estimate)
October 28, 2014
Last Update Submitted That Met QC Criteria
October 24, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAE-1234
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaNot yet recruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive Impairment
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University Health Network, TorontoRecruiting
-
Wake Forest University Health SciencesActive, not recruiting
Clinical Trials on Exercise Intervention
-
VA Office of Research and DevelopmentRecruitingMobility Impairment | Asymptomatic Carotid Stenosis (50-69%)United States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of AarhusNot yet recruiting
-
Glasgow Caledonian UniversityUnknown
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation TrustCompletedQuality of Life | Systemic Sclerosis | Raynaud's PhenomenonUnited Kingdom
-
VA Office of Research and DevelopmentCompletedHeart FailureUnited States
-
University Medical Center GroningenDutch Kidney Foundation; Innovation Fund of the Dutch Medical Insurance CompaniesCompletedMetabolic Syndrome | Kidney Transplant | Post-transplant Weight GainNetherlands
-
Istanbul UniversityCompletedGlenohumeral ArthritisTurkey
-
Aristotle University Of ThessalonikiCompleted